TRACE-ELEMENTS AND LIPID-PEROXIDATION ABNORMALITIES IN PATIENTS WITH CHRONIC-RENAL-FAILURE

被引:247
作者
RICHARD, MJ
ARNAUD, J
JURKOVITZ, C
HACHACHE, T
MEFTAHI, H
LAPORTE, F
FORET, M
FAVIER, A
CORDONNIER, D
机构
[1] CHR UNIV GRENOBLE,SERV HEMODIALYSE,GRENOBLE,FRANCE
[2] CHR UNIV GRENOBLE,AGDUC,GRENOBLE,FRANCE
[3] CHR UNIV GRENOBLE,ENZYMOL LAB,GRENOBLE,FRANCE
来源
NEPHRON | 1991年 / 57卷 / 01期
关键词
D O I
10.1159/000186208
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Plasma selenium (Se), zinc (Zn) and copper (Cu) levels and antioxidant metalloenzymes, glutathione peroxidase (GPX) and superoxide dismutase (SOD), were studied in 17 patients on maintenance hemodialysis (HD) (group I), 14 uremic patients (group II) and 14 healthy subjects (group III). Plasma Se levels and erythrocyte GPX were significantly lower in the HD group (for Se: 0.69 ± 0.12 vs. 1.05 ± 0.13 μmol/l in controls; for erythrocyte GPX: 34.4 ± 6.4 vs. 49.2 ± 9 IU/g hemoglobin in controls) and a significant correlation was found between the two parameters (r = 0.66, p < 0.005). There was also a correlation between decreased plasma Zn and erythrocyte SOD activity (r = 0.58, p < 0.02) and between decreased plasma Cu and erythrocyte SOD (r = 0.60, p < 0.02). Plasma malondialdehyde levels were augmented in HD patients (5.08 ± 0.26 vs. 2.55 ± 0.15 μmol/l in controls and 2.79 ± 0.40 μmol/l in the uremic group). The catalase activity was increased in HD patients (202 ± 24 vs. 140 ± 40 IU/mg hemoglobin in group III). A defective antioxidant activity may thus contribute to increased peroxidative damage to cells in the course of dialysis.
引用
收藏
页码:10 / 15
页数:6
相关论文
共 23 条
[1]   LUMINOL ASSAY FOR SUPEROXIDE-DISMUTASE [J].
BENSINGER, RE ;
JOHNSON, CM .
ANALYTICAL BIOCHEMISTRY, 1981, 116 (01) :142-145
[2]  
CORNELIS R, 1979, MINER ELECTROL METAB, V2, P88
[3]   HEMODIALYSIS LEUKOPENIA - PULMONARY VASCULAR LEUKOSTASIS RESULTING FROM COMPLEMENT ACTIVATION BY DIALYZER CELLOPHANE MEMBRANES [J].
CRADDOCK, PR ;
FEHR, J ;
DALMASSO, AP ;
BRIGHAM, KL ;
JACOB, HS .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 59 (05) :879-888
[4]   PLASMA MALONALDEHYDE LEVELS DURING MYOCARDIAL-INFARCTION [J].
DOUSSET, JC ;
TROUILH, M ;
FOGLIETTI, MJ .
CLINICA CHIMICA ACTA, 1983, 129 (03) :319-322
[5]   DIMINISHED BLOOD SELENIUM LEVELS IN RENAL-FAILURE PATIENTS ON DIALYSIS - CORRELATIONS WITH NUTRITIONAL-STATUS [J].
DWORKIN, B ;
WESELEY, S ;
ROSENTHAL, WS ;
SCHWARTZ, EM ;
WEISS, L .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1987, 293 (01) :6-12
[6]  
FAVIER A, 1984, TRACE ELEMENT ANAL C, V3, P711
[7]  
FLOHE L, 1984, METHOD ENZYMOL, V105, P93
[8]   REDUCED PLASMA AND WHITE BLOOD-CELL SELENIUM LEVELS IN HEMODIALYSIS-PATIENTS [J].
FOOTE, JW ;
HINKS, LJ ;
LLOYD, B .
CLINICA CHIMICA ACTA, 1987, 164 (03) :323-328
[9]  
FORMAN HJ, 1973, J BIOL CHEM, V248, P2645
[10]  
GUNZLER WA, 1974, Z KLIN CHEM KLIN BIO, V12, P444